About Us

We offer a range of advanced biomedical tests, including gut microbiome testing, and use probiotics to formulate personalised gut treatment plans that precisely relieve the common health problems of modern urban living.

Built on gut DNA testing and our patented probiotics, we replenish exactly what each individual needs to improve a wide range of health conditions.

Scientific Advisory Board

Prof. Stephen Tsui Kwok Wing

Professor and Associate Director (Research), School of Biomedical Sciences, The Chinese University of Hong Kong; Programme Director, Genomics and Bioinformatics Programme, CUHK

Prof. Tsui is Professor and Associate Director (Research) of the School of Biomedical Sciences, Programme Director of the Genomics and Bioinformatics Programme at The Chinese University of Hong Kong, Director of the Centre for Microbial Genomics and Proteomics, Director of the Hong Kong Bioinformatics Centre, a member of the Institute of Vascular Medicine and a member of the Hong Kong Society for Biochemistry and Molecular Biology, among others. Prof. Tsui received his PhD in Biochemistry from The Chinese University of Hong Kong (CUHK) in 1995, was appointed Assistant Professor in the Department of Biochemistry at CUHK in 1997 and was promoted to Professor in 2004. He is also a former member of the International HapMap Consortium, where he worked on single-nucleotide polymorphisms of human chromosome 3p. His main research interests are next-generation sequencing, bioinformatics, human genetic diseases and molecular microbiology.

Prof. Lin Zhixiu

Director, School of Chinese Medicine, The Chinese University of Hong Kong; Director, Hong Kong Institute of Integrative Medicine

Prof. Lin Zhixiu graduated in Chinese Medicine from the Guangzhou College of Traditional Chinese Medicine, China, in 1987 and obtained his PhD in Pharmacognosy from King’s College London, University of London, in 1999. With extensive professional experience, Prof. Lin serves as Director of the School of Chinese Medicine at The Chinese University of Hong Kong and, since 2017, as Director of the Hong Kong Institute of Integrative Medicine. His areas of expertise include clinical Chinese medicine, clinical trials of Chinese medicines and Chinese medicine pharmacology. Prof. Lin also focuses on research into different Chinese medicines, such as experimental studies of Chinese medicine for the treatment of psoriasis and the development of topical anti-psoriasis herbal preparations, and studies of the chemical constituents and molecular mechanisms of the Chinese herb Brucea javanica in the treatment of pancreatic cancer.

Dr. Steven Loo King Fan

Specialist in Dermatology; Honorary Clinical Assistant Professor, The Chinese University of Hong Kong

Dr. Loo holds an MBChB from The Chinese University of Hong Kong and is a Member of the Royal College of Physicians (UK), a Fellow of the Hong Kong College of Physicians, a Fellow of the Hong Kong Academy of Medicine (Medicine), holds an MSc in Endocrinology and Diabetes Management and an MSc in Genomics and Bioinformatics from The Chinese University of Hong Kong, and is a Fellow of the Royal College of Physicians of Edinburgh.

Laboratory Team

Mr. Cheung Chun Hin

Laboratory Manager

Mr. Cheung holds a Bachelor’s degree in Biomedical Sciences and has five years of laboratory management experience. During the pandemic he carried out data analysis and coordination at the Hong Kong “Fire Eye” laboratory, helping to set up a temporary air-inflated laboratory for high-throughput virus testing, and also served as a quality-monitoring officer to ensure that laboratory procedures ran correctly. After the pandemic he performed newborn screening for inherited metabolic disorders at a large medical diagnostic centre, identifying disease risks in newborns so that treatment could begin as early as possible. His current responsibilities include establishing sample handling and storage procedures, performing sample testing and preparing data, monitoring test quality, conducting internal test evaluations, writing laboratory operating documents and acting as the client contact for special testing projects.

Dr. Hou Jinpao

Chief Technology Officer

Dr. Hou graduated from The Chinese University of Hong Kong in 2019 with a PhD in Biomedical Sciences. She holds a Bachelor’s degree in Biotechnology and has in-depth knowledge of biochemistry, molecular biology, microbiology and physiology. With a unique blend of dry-lab and wet-lab expertise and more than 9 years of experience, Dr. Hou specialises in the bioinformatic analysis of multi-omics data from clinical studies and in deriving meaningful biological insights from it. She has published 18 scientific articles in journals including the Journal of Allergy and Clinical Immunology, Microbiology Spectrum, Molecular Biology and Evolution and Cell Communication and Signaling, and has served as a peer reviewer for more than 50 manuscripts from 18 scientific journals, mainly in the fields of cancer biology, immunotherapy and human allergic diseases. Dr. Hou is also Vice-Chairperson of the Hong Kong Society of Gut Microbiome. She leads the bioinformatics R&D team, focusing on AI-based metagenomics research projects and translating microbiome science into commercial health-promotion products.

Our manufacturing facility has over fifty years of pharmaceutical experience

Closely monitored probiotic cultivation for the finest quality

Our production facility in Taiwan operates independent health-food and pharmaceutical production lines, with continuous monitoring throughout the entire manufacturing process to ensure the safety and efficacy of product quality. In 2014 it obtained PIC/S GMP certification, the highest international pharmaceutical manufacturing standard, and has been verified by SGS (SGS Taiwan Ltd.) with FSSC 22000 (Food Safety System), ISO 22000 (Food Safety Management System) and HACCP (Hazard Analysis and Critical Control Points) certifications, giving our customers the greatest peace of mind.